An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands.

MLA

van der Pol, Simon, et al. “An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands.” Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, vol. 20, no. 3, Mar. 2017, pp. 388–96. EBSCOhost, https://doi.org/10.1016/j.jval.2016.10.015.

APA

van der Pol, S., Degener, F., Postma, M. J., & Vemer, P. (2017). An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands. Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 20(3), 388–396. https://doi.org/10.1016/j.jval.2016.10.015

Chicago

van der Pol, Simon, Fabian Degener, Maarten J Postma, and Pepijn Vemer. 2017. “An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands.” Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research 20 (3): 388–96. doi:10.1016/j.jval.2016.10.015.